Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Does tadalafil give you headaches? This is a common concern for patients prescribed this phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction or benign prostatic hyperplasia. Headaches are a recognised adverse effect of tadalafil, occurring in a significant proportion of users. The frequency varies by dosage, with higher on-demand doses associated with greater incidence. Understanding why tadalafil causes headaches, how common they are, and what can be done to manage them helps patients make informed decisions about their treatment. This article examines the evidence on tadalafil-related headaches and provides practical guidance aligned with UK regulatory and clinical standards.
Summary: Yes, tadalafil commonly causes headaches as a recognised adverse effect, affecting 10–20% of patients taking higher on-demand doses and fewer with lower daily doses.
Yes, tadalafil can cause headaches as a recognised adverse effect. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor licensed in the UK for the treatment of erectile dysfunction and benign prostatic hyperplasia. According to the Medicines and Healthcare products Regulatory Agency (MHRA), headache is very common (affecting ≥1/10 patients) with 10-20 mg on-demand dosing, and common (affecting ≥1/100 to <1/10 patients) with 2.5-5 mg once-daily dosing.
The mechanism behind tadalafil-induced headaches is thought to relate to the drug's pharmacological action. Tadalafil works by inhibiting the PDE5 enzyme, which leads to increased levels of cyclic guanosine monophosphate (cGMP) in smooth muscle cells. This causes vasodilation—the widening of blood vessels—not only in the intended target areas but throughout the body, including cerebral blood vessels. The dilation of blood vessels in the head and neck region is believed to trigger headaches in susceptible individuals.
It is important to note that whilst headaches are a documented side effect, they do not affect everyone who takes tadalafil. The occurrence and severity of headaches can vary considerably between individuals and may depend on factors such as dosage and individual sensitivity. Some patients experience headaches only when first starting treatment, with symptoms diminishing as the body adjusts to the medication. Others may find that headaches persist or occur intermittently throughout treatment. Understanding this variability helps patients and healthcare professionals make informed decisions about continuing therapy and implementing appropriate management strategies.
Headache frequency with tadalafil varies by dosage. According to MHRA data, headaches are very common (affecting ≥1/10 patients) with the 10-20 mg on-demand doses used for erectile dysfunction, and common (affecting ≥1/100 to <1/10 patients) with the 2.5-5 mg daily doses used for erectile dysfunction and benign prostatic hyperplasia.
In pivotal clinical trials for erectile dysfunction, headache rates ranged from approximately 11% to 15% among patients taking tadalafil, compared to 5% in placebo groups. For the lower daily doses (2.5 mg and 5 mg), headache incidence tends to be somewhat lower than with the higher on-demand doses (10 mg and 20 mg). This suggests that headaches may be more frequent at higher doses, possibly reflecting the extent of systemic vasodilation produced by the medication.
When compared to other PDE5 inhibitors available in the UK, tadalafil's headache profile is broadly similar to sildenafil and vardenafil, though individual responses vary. Tadalafil has a notably longer half-life (approximately 17.5 hours) compared to other agents in this class, which means its effects—including potential side effects—may persist for a longer duration.
The timing of headaches can also vary. Some patients may experience headaches beginning within 30 minutes to 2 hours of taking tadalafil, around the time of peak plasma concentrations. Others may experience delayed onset. For those taking daily low-dose tadalafil, headaches may occur at different times or may be more constant but milder in nature. Understanding these patterns can help patients anticipate and manage symptoms more effectively, and assists healthcare professionals in tailoring treatment approaches to individual needs.
Several practical strategies can help minimise or manage tadalafil-related headaches without necessarily discontinuing treatment. For many patients, simple lifestyle modifications and over-the-counter remedies provide adequate relief whilst allowing them to continue benefiting from tadalafil therapy.
Adequate hydration is a fundamental first step in general headache management. Ensuring sufficient fluid intake throughout the day may help reduce symptom severity. Patients should aim to drink water regularly, particularly around the time of medication administration.
Simple analgesia can be effective for managing tadalafil-induced headaches. Paracetamol is generally considered safe to use alongside tadalafil and may provide relief for mild to moderate headaches. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are also options, though patients should follow standard dosing guidance and be aware of contraindications (including those with gastrointestinal, renal or cardiovascular conditions, or those taking anticoagulants). It is advisable to take these medications at the onset of headache symptoms rather than waiting for pain to intensify.
Dose adjustment may be appropriate in some cases. Patients experiencing persistent or severe headaches should consult their GP or prescriber about potentially reducing the tadalafil dose. For those taking on-demand higher doses, switching to a lower daily dose regimen might provide therapeutic benefit with fewer side effects. Conversely, some patients find that their bodies adjust to the medication over time, with headaches diminishing after the first few doses.
Timing of medication can also matter. Tadalafil can be taken with or without food as food does not affect its absorption. Avoiding other vasodilating substances is essential—particularly nitrates (which are absolutely contraindicated with tadalafil), guanylate cyclase stimulators such as riociguat (also contraindicated), and recreational drugs like 'poppers' (amyl nitrite). Caution is advised with alpha-blockers and excessive alcohol, as these can compound headache risk and create dangerous interactions.
Non-pharmacological approaches such as rest in a quiet, darkened room, cold compresses applied to the forehead or neck, and relaxation techniques may provide additional symptomatic relief for some individuals.
If you experience side effects from tadalafil, you can report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.
Whilst headaches are a recognised side effect of tadalafil, certain presentations warrant prompt medical evaluation. Patients should be aware of warning signs that distinguish routine medication side effects from potentially serious complications.
Call 999 or go to A&E immediately if you experience:
Sudden, severe headache with rapid onset (often described as a 'thunderclap' headache), which could indicate a serious vascular event
Headache accompanied by neurological symptoms such as visual disturbances, weakness, numbness, difficulty speaking, confusion, or loss of consciousness
Headache with chest pain, shortness of breath, or palpitations, which may suggest cardiovascular complications
Severe headache with neck stiffness and fever, potentially indicating infection
Sudden decrease or loss of vision in one or both eyes – stop taking tadalafil and seek urgent medical attention
A painful erection lasting more than 4 hours (priapism) – this requires emergency assessment
Any headache that feels different from your usual tadalafil-related headaches in character, location, or severity
Contact your GP or prescriber for routine advice if:
Headaches persist beyond the first few weeks of treatment without improvement
Over-the-counter analgesia provides insufficient relief
Headaches significantly impact your quality of life or daily activities
You are considering stopping tadalafil due to headaches
You wish to discuss dose adjustment or alternative treatment options
Your healthcare provider can conduct a thorough assessment to exclude other causes of headaches, review your complete medication list for potential interactions, and consider whether tadalafil remains the most appropriate treatment for your condition. Alternative PDE5 inhibitors or different therapeutic approaches may be more suitable for some patients.
NICE guidance emphasises the importance of individualised treatment decisions in managing erectile dysfunction and benign prostatic hyperplasia. If headaches are affecting treatment adherence or satisfaction, an open discussion with your healthcare professional can help identify the best path forward, balancing therapeutic benefit against tolerability. Never discontinue prescribed medication without consulting your prescriber, as abrupt cessation may affect your underlying condition management.
Yes, paracetamol is generally safe to use alongside tadalafil and may provide relief for mild to moderate headaches. It is advisable to take it at the onset of symptoms rather than waiting for pain to intensify.
Some patients experience headaches only when first starting tadalafil, with symptoms diminishing as the body adjusts to the medication. However, others may find headaches persist or occur intermittently throughout treatment.
Do not discontinue tadalafil without consulting your prescriber. If headaches are persistent or severe, contact your GP to discuss dose adjustment or alternative treatment options rather than stopping abruptly.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript